Why Are Temporal Pole MRI Changes a CADASIL Hallmark?
At a Glance
White matter changes in the anterior temporal poles and external capsules are a characteristic MRI pattern in CADASIL because the small vessels supplying these regions may be especially vulnerable. The pattern raises suspicion but does not confirm CADASIL; NOTCH3 testing is usually needed.
In this answer
3 sections
When you have an MRI for suspected CADASIL, your doctor will look closely at specific areas of the brain—most notably the temporal poles (the front tips of the temporal lobes, located near the temples) and the external capsules (bands of white matter deep in the brain). While many conditions can cause general changes to the brain’s white matter, MRI lesions in these two specific regions act as a characteristic clue for CADASIL [1][2]. These hallmark signs help raise suspicion for CADASIL and help doctors distinguish it from other diseases that cause white matter changes, such as multiple sclerosis (MS) or typical aging and high blood pressure [1][3].
It is important to understand that these MRI findings are a diagnostic clue, not a measure of your current disability or a strict predictor of your future symptoms.
Why Are the Temporal Poles and External Capsules So Important?
As we age or experience high blood pressure, it is common to develop some white matter changes, often called white matter hyperintensities because they appear as bright white spots on an MRI [4]. These age-related or hypertension-related changes frequently appear around the brain’s fluid-filled spaces (periventricular regions) or in deep white matter [1].
While CADASIL also causes widespread changes in these same periventricular areas, it frequently produces relatively symmetric, bilateral (on both sides of the brain) lesions that heavily impact the anterior temporal poles and external capsules [1][4]. Finding prominent white matter changes in the anterior temporal lobes is highly suggestive of CADASIL and serves as a major signal for neurologists and neuroradiologists to consider it in their diagnosis [2][3].
What Causes These Specific MRI Changes?
CADASIL is caused by pathogenic variants in the NOTCH3 gene, which leads to the abnormal buildup of proteins in the walls of small blood vessels [5]. This buildup causes the blood vessels to thicken, stiffen, and become less effective at delivering oxygen and nutrients—a state called hypoperfusion [6]. This chronic ischemic injury is thought to contribute heavily to the surrounding white matter changes [7].
While the exact biological reason why the temporal poles are so uniquely vulnerable remains incompletely resolved, scientific research suggests a few possibilities:
- Differences in Tissue Composition: MRI studies show that CADASIL lesions in the temporal poles and external capsules have different physical properties than other white matter changes, including a higher water content and distinct signs of altered myelin (the protective coating around nerve fibers) [1][8][9].
- Vessel Vulnerability: The specific small blood vessels supplying these regions might be uniquely sensitive to the cellular changes caused by the altered NOTCH3 protein [10].
- Genetics: The presence of temporal pole lesions may be influenced by the exact type of NOTCH3 variant a person has. For example, some common variants (called cysteine-altering variants) are frequently associated with temporal pole changes, whereas some variants more often seen in East Asian populations may not produce these specific MRI patterns [11][12][13]. However, these are population-level associations rather than reliable predictions for any one person.
Distinguishing CADASIL from Other Conditions
Because CADASIL can cause symptoms like migraines, cognitive changes, and stroke-like episodes, it is frequently misdiagnosed as multiple sclerosis (MS) or attributed solely to typical small vessel disease from high blood pressure [14][3].
Looking at the temporal poles helps doctors prioritize CADASIL:
- Multiple Sclerosis (MS): MS typically causes white matter lesions in different patterns, usually without the heavy, symmetric involvement of the temporal poles or external capsules. Finding lesions in the temporal poles, along with other features like microbleeds (tiny areas of old bleeding) and lacunes (small fluid-filled cavities from previous tiny strokes), provides comparative evidence that points toward a vascular genetic condition like CADASIL rather than MS [14][3][15].
- General Aging and Hypertension: While high blood pressure causes small vessel disease (and CADASIL can certainly coexist with hypertension), a unique pattern of prominent temporal pole involvement—especially in a younger person with a family history of stroke or dementia—raises suspicion for CADASIL [3][1]. Clinicians look at the distribution of lesions together with age, symptoms, and family history.
While temporal pole changes are a classic characteristic of CADASIL, their absence does not exclude the disease [2][11]. Furthermore, an MRI alone cannot confirm CADASIL. Molecular genetic testing is usually preferred to confirm a pathogenic or likely pathogenic NOTCH3 variant [16]. In cases where genetic testing is inconclusive, a specialized skin biopsy can sometimes be used to support the diagnosis [17].
Common questions in this guide
Why do temporal pole white matter lesions suggest CADASIL?
Does a temporal pole lesion prove that I have CADASIL?
Can I have CADASIL if my MRI does not show temporal pole changes?
How are CADASIL MRI changes different from multiple sclerosis or aging?
What test is used to confirm CADASIL?
Can my NOTCH3 variant predict whether I will have temporal pole lesions?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my MRI show white matter changes in the temporal poles or external capsules, and how do they compare to typical age-related changes?
- 2.Are there other imaging signs on my MRI, such as microbleeds or lacunes, that point toward a small-vessel disorder like CADASIL?
- 3.Based on my specific NOTCH3 variant, is it expected that I would or wouldn't have changes in the temporal poles?
- 4.How do the white matter changes in my brain help distinguish my condition from multiple sclerosis or other small-vessel diseases?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Different types of white matter hyperintensities in CADASIL: Insights from 7-Tesla MRI.
De Guio F, Vignaud A, Chabriat H, Jouvent E
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2018; (38(9)):1654-1663 doi:10.1177/0271678X17690164.
PMID: 28128022 - 2
Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).
Stojanov D, Vojinovic S, Aracki-Trenkic A, et al.
Bosnian journal of basic medical sciences 2015; (15(1)):1-8 doi:10.17305/bjbms.2015.247.
PMID: 25725137 - 3
The role of clinical and neuroimaging features in the diagnosis of CADASIL.
Bersano A, Bedini G, Markus HS, et al.
Journal of neurology 2018; (265(12)):2934-2943 doi:10.1007/s00415-018-9072-8.
PMID: 30311053 - 4
Mechanistic advances in factors influencing phenotypic variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a review.
Zhao Y, Lu Y, Wang F, et al.
Frontiers in neurology 2025; (16()):1573052 doi:10.3389/fneur.2025.1573052.
PMID: 40470487 - 5
Mechanisms regulating cerebral hypoperfusion in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Yan X, Shang J, Wang R, et al.
Journal of biomedical research 2022; (36(5)):353-357 doi:10.7555/JBR.36.20220208.
PMID: 36165325 - 6
CADASIL: A NOTCH3-associated cerebral small vessel disease.
Yuan L, Chen X, Jankovic J, Deng H
Journal of advanced research 2024; (66()):223-235 doi:10.1016/j.jare.2024.01.001.
PMID: 38176524 - 7
Insulin-Independent and Dependent Glucose Transporters in Brain Mural Cells in CADASIL.
Panahi M, Rodriguez PR, Fereshtehnejad SM, et al.
Frontiers in genetics 2020; (11()):1022 doi:10.3389/fgene.2020.01022.
PMID: 33101365 - 8
Vanishing White Matter Hyperintensities in CADASIL: A Case Report with Insight into Disease Mechanisms.
Jouvent E, Alili N, Hervé D, Chabriat H
Journal of Alzheimer's disease : JAD 2020; (78(3)):907-910 doi:10.3233/JAD-201086.
PMID: 33074242 - 9
Reduced myelin contributes to cognitive impairment in patients with monogenic small vessel disease.
Denecke J, Dewenter A, Lee J, et al.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2025; (21(5)):e70127 doi:10.1002/alz.70127.
PMID: 40317599 - 10
Multi-omic profiling reveals pericyte and smooth muscle cell contributions to CADASIL pathology in cell-specific Notch3 mutant mice.
Huang Y, Clementel V, Zhang M, et al.
Cell reports 2026; (45(4)):117285 doi:10.1016/j.celrep.2026.117285.
PMID: 41996236 - 11
Genotype-phenotype correlations of cysteine replacement in CADASIL.
Matsushima T, Conedera S, Tanaka R, et al.
Neurobiology of aging 2017; (50()):169.e7-169.e14 doi:10.1016/j.neurobiolaging.2016.10.026.
PMID: 27890607 - 12
Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL.
Muiño E, Gallego-Fabrega C, Cullell N, et al.
International journal of molecular sciences 2017; (18(9)) doi:10.3390/ijms18091964.
PMID: 28902129 - 13
Characterization of CADASIL among the Han Chinese in Taiwan: Distinct Genotypic and Phenotypic Profiles.
Liao YC, Hsiao CT, Fuh JL, et al.
PloS one 2015; (10(8)):e0136501 doi:10.1371/journal.pone.0136501.
PMID: 26308724 - 14
CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags.
Joshi S, Yau W, Kermode A
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2017; (35()):75-77 doi:10.1016/j.jocn.2016.09.025.
PMID: 27773545 - 15
Cerebral Microbleed Burdens in Specific Brain Regions Are Associated With Disease Severity of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.
Chung CP, Chen JW, Chang FC, et al.
Journal of the American Heart Association 2020; (9(13)):e016233 doi:10.1161/JAHA.120.016233.
PMID: 32552418 - 16
CADASIL: Imaging Characteristics and Clinical Correlation.
Zhu S, Nahas SJ
Current pain and headache reports 2016; (20(10)):57 doi:10.1007/s11916-016-0584-6.
PMID: 27591799 - 17
CADASIL: MRI may be normal in the fourth decade of life - a case report.
Samões R, Alves JE, Taipa R, et al.
Cephalalgia : an international journal of headache 2016; (36(11)):1082-1085 doi:10.1177/0333102415618613.
PMID: 26646783
This page is for informational purposes only and does not constitute medical advice. A neurologist or genetics specialist should interpret your MRI findings and any CADASIL testing.
Get notified when new evidence is published on Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.